Overview
Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds faculty appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research program aims to advance equity in kidney disease and hypertension outcomes by focusing on social drivers of health inequities. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award--a $250,000 award granted to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. In 2019, Dr. Crews received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians and the Distinguished Leader Award from the American Society of Nephrology. Dr. Crews is the founding director of the Doctoral Diversity Program, a 2-year, research-intensive post-baccalaureate program of the Johns Hopkins Initiative for Careers in Science and Medicine. Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins.
Dr. Crews is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Arteriovenous Malformation, Kidney Transplant, and Nephrectomy.
Her clinical research consists of co-authoring 274 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Diabetic Nephropathy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Baltimore, MD 21287
4940 Eastern Avenue, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Oney Zuniga is a Nephrologist in Olney, Maryland. Dr. Zuniga is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Diabetic Nephropathy, Magnesium Deficiency, Gitelman Syndrome, Gastrostomy, and Endoscopy. Dr. Zuniga is currently accepting new patients.
Mid Atlantic Nephrology Associates
Jia Liu is a Nephrologist in Columbia, Maryland. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Kidney DiseaseDr. Crews isElite. Learn about Chronic Kidney Disease.
- Distinguished
- Kidney TransplantDr. Crews isDistinguished. Learn about Kidney Transplant.
- Advanced
- Arteriovenous MalformationDr. Crews isAdvanced. Learn about Arteriovenous Malformation.
- End-Stage Renal Disease (ESRD)Dr. Crews isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Experienced
- Acute Kidney FailureDr. Crews isExperienced. Learn about Acute Kidney Failure.
- Diabetic NephropathyDr. Crews isExperienced. Learn about Diabetic Nephropathy.
- High Potassium LevelDr. Crews isExperienced. Learn about High Potassium Level.
- Metabolic AcidosisDr. Crews isExperienced. Learn about Metabolic Acidosis.
- NecrosisDr. Crews isExperienced. Learn about Necrosis.
- NephrectomyDr. Crews isExperienced. Learn about Nephrectomy.